View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
High-dose Melphalan 200 before Autologous Stem Cell Transplantation, Multiple Myeloma
Protocol-ID: 528 V2.1 (Mini), HD MELP 200 before ASCT, MMIndication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
- Stem Cell Transplantation, Autologous; ICD-10 Z94.80
Links
- Aprepitant, granisetron, and dexamethasone for prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan in autologous transplantation for multiple myeloma: results of a randomized, placebo-controlled phase III trial. [PMID]
- Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. [PMID]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 18.11.2021